Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
20 January 2023Website:
http://www.cadrenal.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 03 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
CVKD Latest News
PONTE VEDRA, Fla. , June 11, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions, today announced that the Company will be participating in the Emerging Growth Conference on June 12, 2024.
Cadrenal Therapeutics (NASDAQ: CVKD ) stock is taking off on Wednesday despite a lack of news from the biopharmaceutical company. There have been no new press releases from Cadrenal Therapeutics that explain why its stock is up today.
It has been a tough, quiet year in the market for initial public stock offerings (IPOs) which has investors eagerly searching for high potential IPOs. In the global IPO landscape, the first quarter of 2023 witnessed a total of 299 IPOs, raising an amount of $21.5 billion.
What type of business is Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
What sector is Cadrenal Therapeutics Common Stock in?
Cadrenal Therapeutics Common Stock is in the Healthcare sector
What industry is Cadrenal Therapeutics Common Stock in?
Cadrenal Therapeutics Common Stock is in the Biotechnology industry
What country is Cadrenal Therapeutics Common Stock from?
Cadrenal Therapeutics Common Stock is headquartered in United States
When did Cadrenal Therapeutics Common Stock go public?
Cadrenal Therapeutics Common Stock initial public offering (IPO) was on 20 January 2023
What is Cadrenal Therapeutics Common Stock website?
https://www.cadrenal.com
Is Cadrenal Therapeutics Common Stock in the S&P 500?
No, Cadrenal Therapeutics Common Stock is not included in the S&P 500 index
Is Cadrenal Therapeutics Common Stock in the NASDAQ 100?
No, Cadrenal Therapeutics Common Stock is not included in the NASDAQ 100 index
Is Cadrenal Therapeutics Common Stock in the Dow Jones?
No, Cadrenal Therapeutics Common Stock is not included in the Dow Jones index
When does Cadrenal Therapeutics Common Stock report earnings?
Next earnings report date is not announced yet